Mark A. Velleca, Director at G1 Therapeutics, Inc. (GTHX), sold 40,000 shares at $22.39 ($876K) on 2021-06-15, disclosed to the SEC on 2021-06-17.
Open-market sale of $876k GTHX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.39 | 10,000 | $224K | 25.5% |
| 2 | $21.74 | 10,000 | $217K | 24.8% |
| 3 | $21.74 | 10,000 | $217K | 24.8% |
| 4 | $21.77 | 10,000 | $218K | 24.8% |
| Total | $21.91 avg | 40,000 | $876K | 100% |
| Filing → |
| GTHX | SELL | 2022-09-22 | $270K | — | Filing → |
| GTHX | SELL | 2022-08-18 | $1.0M | — | Filing → |
| GTHX | SELL | 2021-07-15 | $946K | — | Filing → |